May 6, 2025
Title21 is thrilled to announce the formation of our inaugural Advisory Committee, which will bring together five distinguished leaders in cell and gene therapy (CGT) to guide the evolution of our CGT platform!
April 8, 2025
Title21 announces the addition of Jonathan Wofford as the company’s first Chief Commercial Officer (CCO) to oversee the company’s products, sales, and marketing efforts.
December 10, 2024
We are pleased to announce that Tony Pare has assumed the role of CEO for Title21 Health Solutions.